US Markets for Biopsy Devices 2007

SUMMARY

In 2006, the US market for biopsy devices was valued at over $350 million, representing substantial growth over 2005.

This market is comprised of devices used to perform breast, bone, prostate, lung, liver, bladder, endometrial, kidney, and cervical biopsies.

Research Methodology

The following report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.

Secondary sources include:

• Government Sources:
  • Securities and Exchange Commission filings
  • Food and Drug Administration and patent filings
  • National Center for Health Statistics data
• Biopsy Device Companies:
  • Annual reports, product brochures, corporate profiles, etc.
• Internal Databases and Reports:
  • Previous reports on similar/related sources
• General Internet Searches, Medical Literature and Newspaper/Magazine Searches:
  • Identifying various centers of specialization and articles that might provide leads for primary research.

The secondary research stage builds the foundation for the primary research.

The primary research methodology has four steps:

Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is, thus, either discarded or marked as high or low priority. It is then organized appropriately as determined by the structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the implications of the information for the various bariatric market segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes units and US$ and market shares).

Step 3: At this stage, the research is in position for its most important primary phase- expert interviews. Throughout the secondary research, industry and medical experts are identified. These experts are now contacted by telephone and asked to participate in interviews on recent trends and developments in the industry. Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of the particular interviewee, although in most cases, the most important questions are asked of all experts. The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then either augmented, discarded, or adjusted, based on the views and positions put forth. Attempts are made, whenever possible, to cross-check the views of various experts against each other and reach positions of consensus on issues and market numbers.

Step 4: The final stage of primary research involves individual and group analysis by Millennium Research Group. All research results are assessed and cross-checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 US MARKETS FOR BIOPSY DEVICES

• 1.1 Market Overview
• 1.2 Procedure Overview
  • 1.2.1 Image Guidance
• 1.3 Market Analysis
  • 1.3.1 Market Forecast
  • 1.3.2 Market Drivers and Limiters
    • 1.3.2.1 Market Drivers
    • 1.3.2.2 Market Limiters
• 1.4 Competitive Analysis

2.0 BREAST BIOPSY DEVICE MARKET

• 2.1 Market Overview
• 2.2 Procedure Overview
  • 2.2.1 Image Guidance
• 2.3 Market Analysis
  • 2.3.1 Market Forecast
    • 2.3.1.1 Breast Biopsy Devices
    • 2.3.1.2 Breast Biopsy Markers
  • 2.3.2 Market Drivers and Limiters
    • 2.3.2.1 Market Drivers
    • 2.3.2.2 Market Limiters
  • 2.3.3 Competitive Analysis

3.0 BONE BIOPSY DEVICE MARKET

• 3.1 Market Overview
• 3.2 Procedure Overview
• 3.3 Market Analysis
  • 3.3.1 Market Forecast
    • 3.3.1.1 Bone Biopsy Needles
    • 3.3.1.2 Bone Biopsy Trays
  • 3.3.2 Market Drivers and Limiters
    • 3.3.2.1 Market Drivers
    • 3.3.2.2 Market Limiters
• 3.4 Competitive Analysis

4.0 PROSTATE AND BLADDER BIOPSY DEVICE MARKET

• 4.1 Market Overview
• 4.2 Procedure Overview
  • 4.2.1 Prostate Biopsy
  • 4.2.2 Bladder Biopsy
  • 4.2.3 Image Guidance
• 4.3 Market Analysis
  • 4.3.1 Market Forecast
    • 4.3.1.1 Prostate Biopsy Devices
    • 4.3.1.2 Bladder Biopsies Devices
  • 4.3.2 Market Drivers and Limiters
    • 4.3.2.1 Market Drivers
    • 4.3.2.2 Market limiters
• 4.4 Competitive Analysis

5.0 LUNG, LIVER, AND KIDNEY BIOPSY DEVICE MARKET

• 5.1 Market Overview
• 5.2 Procedure Overview
  • 5.2.1 Kidney Biopsy
  • 5.2.2 Liver Biopsy
  • 5.2.3 Lung Biopsy
  • 5.2.4 Image Guidance
• 5.3 Market Analysis
  • 5.3.1 Market Forecast
    • 5.3.1.1 Liver Biopsy Devices
    • 5.3.1.2 Kidney Biopsy Devices
    • 5.3.1.3 Lung Biopsy Devices
  • 5.3.2 Market Drivers and Limiters
    • 5.3.2.1 Market Drivers
    • 5.3.2.2 Market Limiters
• 5.4 Competitive Analysis

6.0 ENDOMETRIAL AND CERVICAL BIOPSY DEVICE MARKET

• 6.1 Market Overview
• 6.2 Procedure Overview
  • 6.2.1 Endometrial Biopsy
  • 6.2.2 Cervical Biopsy
  • 6.2.3 Image Guidance
• 6.3 Market Analysis
  • 6.3.1 Market Forecast
    • 6.3.1.1 Endometrial Biopsy Devices
    • 6.3.1.2 Cervical Biopsy Devices
  • 6.3.2 Market Drivers and Limiters
    • 6.3.2.1 Market Drivers
    • 6.3.2.2 Market Limiters
• 6.4 Competitive Analysis

MRG ACRONYMS AND INITIALISMS

List of Exhibits

Executive Summary

• Exhibit ES-1: US Market for Biopsy Devices, by Segment, US, 2006
• Exhibit ES-2: US Market for Breast Biopsy Devices, by Segment, US (US$), 2005- 2011
• Exhibit ES-3: Procedure Volumes for Bone Biopsy Devices, by Type, US, 2006- 2011
• Exhibit ES-4: US Market for Prostate and Bladder Biopsy Devices, by Segment, US (US$), 2005- 2011
• Exhibit ES-5: US Market for Lung, Liver, and Kidney Biopsy Devices, by Segment, US (US$), 2005- 2011
• Exhibit ES-6: US Market for Endometrial and Cervical Biopsy Devices, US (US$), 2005- 2011
• Exhibit ES-7: Leading Competitors in the US Market for Biopsy Devices, US, 2006

Chapter 1: US Markets for Biopsy Devices

• Exhibit 1-1: US Markets for Biopsy Devices, US (US$), 2005- 2011
• Exhibit 1-2: Biopsy Procedures, by Type, US, 2005- 2011
• Exhibit 1-3: Biopsy Procedures as a Percent of Total, by Type, US, 2006
• Exhibit 1-4: Automatic and Semi-Automatic Biopsy Procedures, by Device, US, 2005- 2011 (Tabular Format)
• Exhibit 1-5: Automatic and Semi-Automatic Biopsy Procedures, by Device, US, 2005- 2011 (Graphical Format)
• Exhibit 1-6: US Biopsy Procedures, by Image Guidance and Anatomy, US, 2005- 2011
• Exhibit 1-7: US Biopsy Procedure Image Guidance, by Type, as a % of Total Procedures, US, 2005- 2011
• Exhibit 1-8: US Biopsy Procedures, by Image Guidance, US, 2006
• Exhibit 1-9: US Biopsy Market, by Type, US, 2006
• Exhibit 1-10: US Biopsy Market, by Type, US (US$), 2005- 2011
• Exhibit 1-11: Population, Total versus Age 50 and Over, US, 2005- 2011
• Exhibit 1-12: Leading Competitors in the US Market for Biopsy Devices, US, 2006 (Tabular Format)
• Exhibit 1-13: Leading Competitors in the US Market for Biopsy Devices, US, 2006 (Graphical Format)

Chapter 2: Breast Biopsy Device Market

• Exhibit 2-1: Breast Biopsy Market, US (US$), 2005- 2011
• Exhibit 2-2: Breast Cancer Incidence, US, 2005- 2011
• Exhibit 2-3: Breast Biopsy Procedures, by Type, US, 2005- 2011
• Exhibit 2-4: Open Surgical Breast Biopsy Procedures, US, 2005- 2011
• Exhibit 2-5: Minimally Invasive Breast Biopsy Procedures, by Method, US, 2005- 2011
• Exhibit 2-6: Image-Guided Breast Biopsy Procedures, by Modality, US, 2005- 2011
• Exhibit 2-7: Breast Biopsy Market, by Segment, US (US$), 2005- 2011
• Exhibit 2-8: Breast Biopsy Device Market, by Segment, US (US$), 2005- 2011
• Exhibit 2-9: VAB Market, by Segment, US (US$), 2005- 2011
• Exhibit 2-10: VAB Disposable Market, US (US$), 2005- 2011
• Exhibit 2-11: VAB Capital Equipment Market, US (US$), 2005- 2011
• Exhibit 2-12: CNB Market, US (US$), 2005- 2011
• Exhibit 2-13: FNA Market, US (US$), 2005- 2011
• Exhibit 2-14: Breast Biopsy Marker Market, by Segment, US (US$), 2005- 2011
• Exhibit 2-15: Stereotactic Mammography Marker Market, US (US$), 2005- 2011
• Exhibit 2-16: Ultrasound Marker Market, US (US$), 2005- 2011
• Exhibit 2-17: MRI Marker Market, US (US$), 2005- 2011
• Exhibit 2-18: Drivers and Limiters of the Breast Biopsy Device Market, US
• Exhibit 2-19: Leading Competitors in the Breast Biopsy Market, US, 2006
• Exhibit 2-20: Leading Competitors in the VAB Market, US, 2005
• Exhibit 2-21: Leading Competitors in the CNB Market, US, 2005
• Exhibit 2-22: Leading Competitors in the FNA Market, US, 2005
• Exhibit 2-23: Leading Competitors in the Marker Market, US, 2005

Chapter 3: Bone Biopsy Device Market

• Exhibit 3-1: US Bone Biopsy Market, US (US$), 2005- 2011
• Exhibit 3-2: Bone Biopsy Procedures, by Type, US, 2005- 2011
• Exhibit 3-3: Bone Biopsy Device Market, by Segment, US, 2005- 2011 (Tabular Format)
• Exhibit 3-4: Bone Biopsy Device Market, by Segment, US, 2005- 2011 (Graphical Format)
• Exhibit 3-5: Bone Biopsy Needle Market, by Segment, US, 2005- 2011
• Exhibit 3-6: Core Bone Needle Market, US, 2005- 2011
• Exhibit 3-7: Fine Bone Aspiration Needle Market, US, 2005- 2011
• Exhibit 3-8: Bone Biopsy Needle Market, by Segment, US, 2005- 2011
• Exhibit 3-9: Core Bone Tray Market, US, 2005- 2011
• Exhibit 3-10: Fine Bone Aspiration Tray Market, US, 2005- 2011
• Exhibit 3-11: Drivers and Limiters of the Bone Biopsy Market, US
• Exhibit 3-12: Population, Total versus Age 50 and Over, US, 2005- 2011
• Exhibit 3-13: Leading Competitors in the Bone Biopsy Device Market, US, 2006 (Tabular Format)
• Exhibit 3-14: Leading Competitors in the Bone Biopsy Device Market, US, 2006 (Graphical Format)

Chapter 4: Prostate and Bladder Biopsy Device Market

• Exhibit 4-1: Prostate and Bladder Biopsy Device Market, US (US$), 2005- 2011
• Exhibit 4-2: PSA Levels (Tabular Format)
• Exhibit 4-3: PSA Levels (Graphical Format)
• Exhibit 4-4: Prostate Biopsy Procedures, US, 2005- 2011
• Exhibit 4-5: Bladder Biopsy Procedures, US, 2005- 2011
• Exhibit 4-6: Bladder Biopsy Procedures, by Image Guidance, US, 2005- 2011
• Exhibit 4-7: Prostate and Bladder Biopsy Procedures, by Device, as a % of Total, US, 2005- 2011
• Exhibit 4-8: Biopsy Procedures, by Device Type, as a % of Total, US, 2005- 2011
• Exhibit 4-9: Prostate and Bladder Biopsy Device Market, US, 2005- 2011
• Exhibit 4-10: Reusable Biopsy Device, Prostate, Bladder Biopsy Device Market, US (US$), 2005- 2011
• Exhibit 4-11: Prostate Biopsy Device Market, by Segment, US, 2005- 2011
• Exhibit 4-12: Disposable Prostate Biopsy Guns, US, 2005- 2011
• Exhibit 4-13: Reusable Prostate Biopsy Guns, US, 2005- 2011
• Exhibit 4-14: Manual Prostate Biopsy Needle Market, US, 2005- 2011
• Exhibit 4-15: Bladder Biopsy Device Market, US, 2005- 2011
• Exhibit 4-16: Disposable Bladder Biopsy Guns, US, 2005- 2011
• Exhibit 4-17: Reusable Bladder Biopsy Guns, US, 2005- 2011
• Exhibit 4-18: Manual Bladder Biopsy Needles, US, 2005- 2011
• Exhibit 4-19: Drivers and Limiters of the Prostate and Bladder Biopsy Market, US
• Exhibit 4-20: Population, Total versus Age 50 and Over, US, 2005- 2011
• Exhibit 4-21: Leading Competitors in the Prostate and Bladder Biopsy Device Market, US, 2006 (Tabular Format)
• Exhibit 4-22: Leading Competitors in the Prostate and Bladder Biopsy Device Market, US, 2006 (Graphical Format)

Chapter 5: Lung, Liver, and Kidney Biopsy Device Market

• Exhibit 5-1: Lung, Liver, and Kidney Biopsy Device Market, US (US$), 2005- 2011
• Exhibit 5-2: Kidney Biopsy Procedures, US, 2005- 2011
• Exhibit 5-3: Kidney Biopsy Procedures, by Device, US, 2005- 2011
• Exhibit 5-4: Liver Biopsy Procedures, US, 2005- 2011
• Exhibit 5-5: Liver Biopsy Procedures, by Device, US, 2005- 2011
• Exhibit 5-6: Lung Biopsy Procedures, US, 2005- 2011
• Exhibit 5-7: Lung Biopsy Procedures, by Device, US, 2005- 2011
• Exhibit 5-8: Kidney Biopsy Procedures, by Physician Type, as a % of Total, US, 2005- 2011
• Exhibit 5-9: Liver Biopsy Procedures, by Physician Type, as a % of Total, US, 2005- 2011
• Exhibit 5-10: Lung Biopsy Procedures, by Physician Type, as a % of Total, US, 2005- 2011
• Exhibit 5-11: Kidney Biopsy Procedures, by Image Guidance, US, 2005- 2011
• Exhibit 5-12: Liver Biopsy Procedures, by Image Guidance, US, 2005- 2011
• Exhibit 5-13: Lung, Liver, and Kidney Biopsy Device Market, US, 2005- 2011
• Exhibit 5-14: Reusable Biopsy Device, Lung, Liver, and Kidney Biopsy Device Market, US (US$), 2005- 2011
• Exhibit 5-15: Liver Biopsy Device Market, by Segment, US, 2005- 2011
• Exhibit 5-16: Disposable Liver Biopsy Needles, US, 2005- 2011
• Exhibit 5-17: Reusable Liver Biopsy Needles, US, 2005- 2011
• Exhibit 5-18: Kidney Biopsy Device Market, US, 2005- 2011
• Exhibit 5-19: Disposable Kidney Biopsy Needle Market, US, 2005- 2011
• Exhibit 5-20: Reusable Kidney Needle Biopsy Market, US, 2005- 2011
• Exhibit 5-21: Lung Biopsy Device Market, by Segment, US, 2005- 2011
• Exhibit 5-22: Disposable Lung Biopsy Needles, US, 2005- 2011
• Exhibit 5-23: Manual Lung Biopsy Needles, US, 2005- 2011
• Exhibit 5-24: Reusable Lung Biopsy Needles, US, 2005- 2011
• Exhibit 5-25: Drivers and Limiters of the Lung, Liver, and Kidney Biopsy Market, US
• Exhibit 5-26: Population, Total versus Age 50 and Over, US, 2005- 2011
• Exhibit 5-27: Leading Competitors in the Lung, Liver, and Kidney Biopsy Device Market, US, 2006 (Tabular Format)
• Exhibit 5-28: Leading Competitors in the Lung, Liver, and Kidney Biopsy Device Market, US, 2006 (Graphical Format)

Chapter 6: Endometrial and Cervical Biopsy Device Market

• Exhibit 6-1: Endometrial and Cervical Biopsy Device Market, US (US$), 2005- 2011
• Exhibit 6-2: Endometrial Biopsy Procedures, US, 2005- 2011
• Exhibit 6-3: Cervical Biopsy Procedures, US, 2005- 2011
• Exhibit 6-4: Endometrial and Cervical Biopsy Device Market, by Segment, 2005- 2011
• Exhibit 6-5: Endometrial Biopsy Curettes, US, 2005- 2011
• Exhibit 6-6: Devices for Cervical Biopsies, US, 2005- 2011
• Exhibit 6-7: Drivers and Limiters of the Endometrial and Cervical Biopsy Market, US
• Exhibit 6-8: Female Population, Total versus Age 50 and Over, US, 2005- 2011
• Exhibit 6-9: Leading Competitors in the Endometrium and Cervical Biopsy Device Market, US, 2006 (Tabular Format)
• Exhibit 6-10: Leading Competitors in the Endometrium and Cervical Biopsy Device Market, US, 2006 (Graphical Format)